# Hain Celestial Group Inc: financial statements, quarterly

HAIN · Nasdaq · CIK 910406 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/hain.md) · [Financials](/companies/hain/financials.md) · [Filings](/companies/hain/filings.md) · [Insiders](/companies/hain/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hain/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [425](/filings/0000950170-24-123246.md) | [454](/filings/0000950170-25-017025.md) | [438](/filings/0000950170-25-065632.md) | [419 d](/filings/0001193125-25-203534.md) | [395](/filings/0001193125-25-272288.md) | [411](/filings/0001193125-26-041911.md) | [390](/filings/0001193125-26-216701.md) | [363 d](/filings/0001193125-26-390505.md) | [368](/filings/0001193125-25-272288.md) | [384](/filings/0001193125-26-041911.md) | [338](/filings/0001193125-26-216701.md) | [263 d](/filings/0001193125-26-390505.md) |
| Cost of revenue | $m | [341](/filings/0000950170-24-123246.md) | [352](/filings/0000950170-25-017025.md) | [342](/filings/0000950170-25-065632.md) | [321 d](/filings/0001193125-25-203534.md) | [313](/filings/0001193125-25-272288.md) | [318](/filings/0001193125-26-041911.md) | [306](/filings/0001193125-26-216701.md) | [289 d](/filings/0001193125-26-390505.md) | [300](/filings/0001193125-25-272288.md) | [310](/filings/0001193125-26-041911.md) | [268](/filings/0001193125-26-216701.md) | [204 d](/filings/0001193125-26-390505.md) |
| Gross profit | $m | [83.9](/filings/0000950170-24-123246.md) | [102](/filings/0000950170-25-017025.md) | [96.7](/filings/0000950170-25-065632.md) | [98.0 d](/filings/0001193125-25-203534.md) | [81.6](/filings/0001193125-25-272288.md) | [93.5](/filings/0001193125-26-041911.md) | [84.7](/filings/0001193125-26-216701.md) | [74.3 d](/filings/0001193125-26-390505.md) | [68.1](/filings/0001193125-25-272288.md) | [74.4](/filings/0001193125-26-041911.md) | [70.4](/filings/0001193125-26-216701.md) | [59.2 d](/filings/0001193125-26-390505.md) |
| Selling, general and administrative | $m | [77.2](/filings/0000950170-24-123246.md) | [74.0](/filings/0000950170-25-017025.md) | [66.7](/filings/0000950170-25-065632.md) | [72.3 d](/filings/0001193125-25-203534.md) | [71.3](/filings/0001193125-25-272288.md) | [70.2](/filings/0001193125-26-041911.md) | [62.9](/filings/0001193125-26-216701.md) | [67.4 d](/filings/0001193125-26-390505.md) | [65.5](/filings/0001193125-25-272288.md) | [60.9](/filings/0001193125-26-041911.md) | [59.1](/filings/0001193125-26-216701.md) | [62.5 d](/filings/0001193125-26-390505.md) |
| Operating income | $m | [(2.3)](/filings/0000950170-24-123246.md) | [(0.8)](/filings/0000950170-25-017025.md) | [(27.9)](/filings/0000950170-25-065632.md) | [12.0 d](/filings/0001193125-25-203534.md) | [3.1](/filings/0001193125-25-272288.md) | [(91.9)](/filings/0001193125-26-041911.md) | [(121)](/filings/0001193125-26-216701.md) | [(252) d](/filings/0001193125-26-390505.md) | [(6.9)](/filings/0001193125-25-272288.md) | [(98.8)](/filings/0001193125-26-041911.md) | [(42.1)](/filings/0001193125-26-216701.md) | [(55.7) d](/filings/0001193125-26-390505.md) |
| Income tax | $m | [(5.4)](/filings/0000950170-24-123246.md) | [(4.2)](/filings/0000950170-25-017025.md) | [5.1](/filings/0000950170-25-065632.md) | [(3.3) d](/filings/0001193125-25-203534.md) | [3.5](/filings/0001193125-25-272288.md) | [2.7](/filings/0001193125-26-041911.md) | [(0.5)](/filings/0001193125-26-216701.md) | [9.6 d](/filings/0001193125-26-390505.md) | [(1.3)](/filings/0001193125-25-272288.md) | [2.4](/filings/0001193125-26-041911.md) | [0.8](/filings/0001193125-26-216701.md) | [(4.1) d](/filings/0001193125-26-390505.md) |
| Net income | $m | [(10.4)](/filings/0000950170-25-065632.md) | [(13.5)](/filings/0000950170-25-065632.md) | [(48.2)](/filings/0000950170-25-065632.md) | [(2.9) d](/filings/0001193125-25-203534.md) | [(19.7)](/filings/0001193125-26-216701.md) | [(104)](/filings/0001193125-26-216701.md) | [(135)](/filings/0001193125-26-216701.md) | [(273) d](/filings/0001193125-26-390505.md) | [(20.6)](/filings/0001193125-26-216701.md) | [(116)](/filings/0001193125-26-216701.md) | [(106)](/filings/0001193125-26-216701.md) | [(61.9) d](/filings/0001193125-26-390505.md) |
| Diluted EPS | $ per share | [(0.12)](/filings/0000950170-24-123246.md) | [(0.15)](/filings/0000950170-25-017025.md) | [(0.54)](/filings/0000950170-25-065632.md) | not reported | [(0.22)](/filings/0001193125-25-272288.md) | [(1.15)](/filings/0001193125-26-041911.md) | [(1.49)](/filings/0001193125-26-216701.md) | not reported | [(0.23)](/filings/0001193125-25-272288.md) | [(1.28)](/filings/0001193125-26-041911.md) | [(1.17)](/filings/0001193125-26-216701.md) | not reported |
| Basic EPS | $ per share | [(0.12)](/filings/0000950170-24-123246.md) | [(0.15)](/filings/0000950170-25-017025.md) | [(0.54)](/filings/0000950170-25-065632.md) | not reported | [(0.22)](/filings/0001193125-25-272288.md) | [(1.15)](/filings/0001193125-26-041911.md) | [(1.49)](/filings/0001193125-26-216701.md) | not reported | [(0.23)](/filings/0001193125-25-272288.md) | [(1.28)](/filings/0001193125-26-041911.md) | [(1.17)](/filings/0001193125-26-216701.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [38.3](/filings/0000910406-23-000114.md) | [53.7](/filings/0000910406-24-000016.md) | [49.5](/filings/0000910406-24-000038.md) | [54.3](/filings/0001193125-25-203534.md) | [56.9](/filings/0000950170-24-123246.md) | [56.2](/filings/0000950170-25-017025.md) | [44.4](/filings/0000950170-25-065632.md) | [54.4](/filings/0001193125-26-390505.md) | [47.9](/filings/0001193125-25-272288.md) | [68.0](/filings/0001193125-26-041911.md) | [44.3](/filings/0001193125-26-216701.md) | [58.1](/filings/0001193125-26-390505.md) |
| Current assets | $m | [566](/filings/0000910406-23-000114.md) | [599](/filings/0000910406-24-000016.md) | [572](/filings/0000910406-24-000038.md) | [557](/filings/0001193125-25-203534.md) | [564](/filings/0000950170-24-123246.md) | [548](/filings/0000950170-25-017025.md) | [552](/filings/0000950170-25-065632.md) | [530](/filings/0001193125-26-390505.md) | [523](/filings/0001193125-25-272288.md) | [564](/filings/0001193125-26-041911.md) | [436](/filings/0001193125-26-216701.md) | [416](/filings/0001193125-26-390505.md) |
| Total assets | $m | [2,217](/filings/0000910406-23-000114.md) | [2,234](/filings/0000910406-24-000016.md) | [2,149](/filings/0000910406-24-000038.md) | [2,118](/filings/0001193125-25-203534.md) | [2,135](/filings/0000950170-24-123246.md) | [1,961](/filings/0000950170-25-017025.md) | [1,844](/filings/0000950170-25-065632.md) | [1,603](/filings/0001193125-26-390505.md) | [1,583](/filings/0001193125-25-272288.md) | [1,477](/filings/0001193125-26-041911.md) | [1,163](/filings/0001193125-26-216701.md) | [1,090](/filings/0001193125-26-390505.md) |
| Current liabilities | $m | [247](/filings/0000910406-23-000114.md) | [267](/filings/0000910406-24-000016.md) | [272](/filings/0000910406-24-000038.md) | [282](/filings/0001193125-25-203534.md) | [281](/filings/0000950170-24-123246.md) | [289](/filings/0000950170-25-017025.md) | [305](/filings/0000950170-25-065632.md) | [277](/filings/0001193125-26-390505.md) | [277](/filings/0001193125-25-272288.md) | [1,017](/filings/0001193125-26-041911.md) | [835](/filings/0001193125-26-216701.md) | [831](/filings/0001193125-26-390505.md) |
| Total liabilities | $m | [1,236](/filings/0000910406-23-000114.md) | [1,238](/filings/0000910406-24-000016.md) | [1,205](/filings/0000910406-24-000038.md) | [1,175](/filings/0001193125-25-203534.md) | [1,171](/filings/0000950170-24-123246.md) | [1,156](/filings/0000950170-25-017025.md) | [1,147](/filings/0000950170-25-065632.md) | [1,128](/filings/0001193125-26-390505.md) | [1,138](/filings/0001193125-25-272288.md) | [1,147](/filings/0001193125-26-041911.md) | [947](/filings/0001193125-26-216701.md) | [936](/filings/0001193125-26-390505.md) |
| Long-term debt | $m | not reported | not reported | not reported | [746](/filings/0000950170-24-100992.md) | not reported | not reported | not reported | [707](/filings/0001193125-25-203534.md) | not reported | not reported | not reported | [558](/filings/0001193125-26-390505.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [981](/filings/0000950170-25-065632.md) | [996](/filings/0000950170-25-065632.md) | [944](/filings/0000950170-25-065632.md) | [943](/filings/0001193125-26-390505.md) | [964](/filings/0001193125-26-216701.md) | [805](/filings/0001193125-26-216701.md) | [697](/filings/0001193125-26-216701.md) | [475](/filings/0001193125-26-390505.md) | [445](/filings/0001193125-26-216701.md) | [330](/filings/0001193125-26-216701.md) | [216](/filings/0001193125-26-216701.md) | [155](/filings/0001193125-26-390505.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [14.0](/filings/0000950170-24-123246.md) | [20.7 d](/filings/0000950170-25-017025.md) | [42.3 d](/filings/0000950170-25-065632.md) | [39.4 d](/filings/0001193125-25-203534.md) | [(10.8)](/filings/0001193125-25-272288.md) | [30.9 d](/filings/0001193125-26-041911.md) | [4.6 d](/filings/0001193125-26-216701.md) | [(2.6) d](/filings/0001193125-26-390505.md) | [(8.5)](/filings/0001193125-25-272288.md) | [37.0 d](/filings/0001193125-26-041911.md) | [38.3 d](/filings/0001193125-26-216701.md) | [11.4 d](/filings/0001193125-26-390505.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [89.5](/filings/0000910406-23-000114.md) | [89.6](/filings/0000910406-24-000016.md) | [89.4](/filings/0000910406-24-000038.md) | [89.5](/filings/0000950170-24-123246.md) | [89.8](/filings/0000950170-25-017025.md) | [89.8](/filings/0000950170-25-065632.md) | [89.9](/filings/0001193125-25-272288.md) | [90.1](/filings/0001193125-26-041911.md) | [90.2](/filings/0001193125-26-216701.md) | [90.3](/filings/0001193125-25-272288.md) | [90.7](/filings/0001193125-26-041911.md) | [91.0](/filings/0001193125-26-216701.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 91,002,269 at 2026-10-20, from the cover of the [10-K/A filed 2026-10-23](/filings/0001193125-26-430619.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.